AAV2/8-HLP-FVIII-V3 for hemophilia a

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Dec 2016: Trial registered, NCT03001830
  2. 14 Jun 2017: Trial started, NCT03001830

The trials

NCT03001830: Gene Therapy for Haemophilia A.

State
Under way
Phase
Phase 1 and Phase 2
People
14 taking part
Started
14 Jun 2017
Primary completion
Jan 2029
Arms
Treatment Arm
Results
None posted
  1. 23 Dec 2016: Trial registered
  2. 14 Jun 2017: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.